# Bispebjerg Hospital

Organization · id `cardio:org-bispebjerg-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 00td68a17](<https://ror.org/00td68a17>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 00td68a17 by an exact name.

## The registry's words

- Sponsor name: Bispebjerg Hospital
- Sponsor class: OTHER
- ROR name: Bispebjerg Hospital

## Connected pages

- Sponsors: Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome. (`cardio:ct-nct02034526`)
- Sponsors: Atrial Fibrillation Detected by Continuous ECG Monitoring (`cardio:ct-nct02036450`)
- Sponsors: Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction (`cardio:ct-nct03778554`)
- Sponsors: A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure (`cardio:ct-nct03984591`)
- Sponsors: Cost-effectiveness and Safety of the CADScorSystem in Patients With Symptoms Suggestive of Stable Coronary Artery Disease. (`cardio:ct-nct04121949`)
- Sponsors: Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial (`cardio:ct-nct05173896`)
- Sponsors: DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure (`cardio:ct-nct05276219`)
- Sponsors: Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke (`cardio:ct-nct05630586`)
- Sponsors: Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes (`cardio:ct-nct06082063`)

## Provenance

Content hash: f119ef2d12376ce70314a90df6715d8ac0fa4f5792bbf95a28a208da8817c0b7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
